Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China
暂无分享,去创建一个
Huaqing Zhao | Zongxing Yang | Y. Xun | A. Xu | Miao-chan Wang | Ying Wang | Fang Liu | J. Bao | Brona Ranieri | Chen Chen | Guoxiang Zheng
[1] G. Guaraldi,et al. Kidney Disease in HIV Infection , 2019, Journal of clinical medicine.
[2] R. Tsonaka,et al. Pitfalls of linear regression for estimating slopes over time and how to avoid them by using linear mixed-effects models. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] S. Kerr,et al. Changes in renal function with long‐term exposure to antiretroviral therapy in HIV‐infected adults in Asia , 2018, Pharmacoepidemiology and drug safety.
[4] E. Igumbor,et al. Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study , 2017, Journal of the International AIDS Society.
[5] J. Nachega,et al. Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens , 2016, AIDS.
[6] S. Ye,et al. Application of Modified Glomerular Filtration Rate Estimation Equations in Chinese Diabetic Patients with Chronic Kidney Diseases. , 2015, West Indian medical journal.
[7] N. Ford,et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. , 2015, The Lancet. Global health.
[8] H. Yazaki,et al. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up , 2014, AIDS.
[9] H. Khalili,et al. Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention , 2014, European Journal of Clinical Pharmacology.
[10] A. Muñoz,et al. Nonlinear trajectory of GFR in children before RRT. , 2014, Journal of the American Society of Nephrology : JASN.
[11] S. Khoo,et al. Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity , 2014, AIDS.
[12] C. Leen,et al. Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure , 2014, The Journal of infectious diseases.
[13] J. Nachega,et al. Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] H. Trottier,et al. Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Peter Reiss,et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. , 2013, The Journal of infectious diseases.
[16] C. Huerta,et al. Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case–control study , 2013, BMJ Open.
[17] P. Easterbrook,et al. The next generation of the World Health Organization's global antiretroviral guidance , 2013, Journal of the International AIDS Society.
[18] Liang Li,et al. Longitudinal progression trajectory of GFR among patients with CKD. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] R. Weber,et al. Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir , 2012, AIDS.
[20] Patrick Royston,et al. Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.
[21] M. Tonelli,et al. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] L. Hurley,et al. Impact of Tenofovir on Renal Function in HIV-Infected, Antiretroviral-Naive Patients , 2010, Journal of acquired immune deficiency syndromes.
[23] Peter C Austin,et al. Report Card on Propensity-Score Matching in the Cardiology Literature From 2004 to 2006: A Systematic Review , 2008, Circulation. Cardiovascular quality and outcomes.
[24] R. Ebrahimi,et al. Pharmacokinetics and Safety of Tenofovir Disoproxil Fumarate on Coadministration With Lopinavir/Ritonavir , 2006, Journal of acquired immune deficiency syndromes.
[25] Tom Greene,et al. Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.
[26] Rajeev Dehejia,et al. Propensity Score-Matching Methods for Nonexperimental Causal Studies , 2002, Review of Economics and Statistics.
[27] D. Rubin,et al. Estimating and Using Propensity Scores with Partially Missing Data , 2000 .
[28] H. Parving,et al. Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] A. Mocroft,et al. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. , 2016, The lancet. HIV.
[30] Lena Osterhagen,et al. Multiple Imputation For Nonresponse In Surveys , 2016 .
[31] Brenda R. Hemmelgarn,et al. Notice , 2012, Kidney International Supplements.
[32] Gfr Investigation. Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease , 2006 .